Pages that link to "Q30175321"
Jump to navigation
Jump to search
The following pages link to SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef. (Q30175321):
Displaying 28 items.
- Further studies on hepatitis C virus NS5A-SH3 domain interactions: identification of residues critical for binding and implications for viral RNA replication and modulation of cell signalling (Q24298665) (← links)
- Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome (Q24299721) (← links)
- The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity (Q24313430) (← links)
- A novel, non-immunogenic Fyn SH3-derived binding protein with tumor vascular targeting properties (Q24320137) (← links)
- Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways (Q24563306) (← links)
- HIV-1 Infection of T Lymphocytes and Macrophages Affects Their Migration via Nef (Q26779194) (← links)
- SH3 domains come of age (Q27016028) (← links)
- Conformation of the dileucine-based sorting motif in HIV-1 Nef revealed by intermolecular domain assembly (Q27667185) (← links)
- Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody (Q27682132) (← links)
- Molecular design, functional characterization and structural basis of a protein inhibitor against the HIV-1 pathogenicity factor Nef (Q28478210) (← links)
- High-affinity target binding engineered via fusion of a single-domain antibody fragment with a ligand-tailored SH3 domain (Q28480982) (← links)
- Structural studies and SH3 domain binding properties of a human antiviral salivary proline-rich peptide (Q30008905) (← links)
- Preferred SH3 domain partners of ADAM metalloproteases include shared and ADAM-specific SH3 interactions (Q30009199) (← links)
- Transient protein-protein interaction of the SH3-peptide complex via closely located multiple binding sites (Q30010150) (← links)
- HIV-1 Nef interaction influences the ATP-binding site of the Src-family kinase, Hck (Q30010155) (← links)
- Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions (Q30010165) (← links)
- Versatile retargeting of SH3 domain binding by modification of non-conserved loop residues (Q30158003) (← links)
- Functional genomics of intracellular peptide recognition domains with combinatorial biology methods (Q30164943) (← links)
- How SH3 domains recognize proline (Q30165044) (← links)
- Phage display in pharmaceutical biotechnology (Q30974739) (← links)
- Selection of human antibody fragments by phage display (Q33305820) (← links)
- NextGen protein design (Q33732694) (← links)
- Sequence- and interactome-based prediction of viral protein hotspots targeting host proteins: a case study for HIV Nef. (Q33954592) (← links)
- HIV Protein Sequence Hotspots for Crosstalk with Host Hub Proteins (Q33999393) (← links)
- Novel therapy based on camelid nanobodies (Q38151739) (← links)
- Shark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development (Q38236706) (← links)
- MC159 of Molluscum Contagiosum Virus Suppresses Autophagy by Recruiting Cellular SH3BP4 via an SH3 Domain-Mediated Interaction (Q92177893) (← links)
- Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis (Q93090744) (← links)